Patents Assigned to National Defense Education and Research Foundation
  • Publication number: 20230082397
    Abstract: A new compound composition that is free of a side effect to a liver and used for alleviating the toxicity of an acetaminophen (APAP) medicament to the liver. The compound composition comprises (a) a pharmaceutically effective amount of acetaminophen and (b) a frequently-used safe and pharmaceutically acceptable excipient that can be combined with one or more than two medicaments that can reduce the toxicity of a drug via liver enzyme CYP2E1 metabolism to the liver.
    Type: Application
    Filed: November 23, 2022
    Publication date: March 16, 2023
    Applicant: NATIONAL DEFENSE EDUCATION AND RESEARCH FOUNDATION
    Inventors: Oliver Yoa-Pu HU, Tung-Yuan SHIH
  • Patent number: 11534416
    Abstract: A new compound composition that is free of a side effect to a liver and used for alleviating the toxicity of an acetaminophen (APAP) medicament to the liver. The compound composition comprises (a) a pharmaceutically effective amount of acetaminophen and (b) a frequently-used safe and pharmaceutically acceptable excipient that can be combined with one or more than two medicaments that can reduce the toxicity of a drug via liver enzyme CYP2E1 metabolism to the liver.
    Type: Grant
    Filed: May 14, 2019
    Date of Patent: December 27, 2022
    Assignee: NATIONAL DEFENSE EDUCATION AND RESEARCH FOUNDATION
    Inventors: Oliver Yoa-Pu Hu, Tung-Yuan Shih
  • Patent number: 10420737
    Abstract: A new compound composition that is free of a side effect to a liver and used for alleviating the toxicity of an acetaminophen (APAP) medicament to the liver. The compound composition comprises (a) a pharmaceutically effective amount of acetaminophen and (b) a frequently-used safe and pharmaceutically acceptable excipient that can be combined with one or more than two medicaments that can reduce the toxicity of a drug via liver enzyme CYP2E1 metabolism to the liver.
    Type: Grant
    Filed: November 13, 2013
    Date of Patent: September 24, 2019
    Assignee: NATIONAL DEFENSE EDUCATION AND RESEARCH FOUNDATION
    Inventors: Oliver Yao-Pu Hu, Tung-Yuan Shih
  • Publication number: 20190262289
    Abstract: A new compound composition that is free of a side effect to a liver and used for alleviating the toxicity of an acetaminophen (APAP) medicament to the liver. The compound composition comprises (a) a pharmaceutically effective amount of acetaminophen and (b) a frequently-used safe and pharmaceutically acceptable excipient that can be combined with one or more than two medicaments that can reduce the toxicity of a drug via liver enzyme CYP2E1 metabolism to the liver.
    Type: Application
    Filed: May 14, 2019
    Publication date: August 29, 2019
    Applicant: NATIONAL DEFENSE EDUCATION AND RESEARCH FOUNDATION
    Inventors: Oliver Yoa-Pu HU, Tung-Yuan SHIH
  • Publication number: 20180325840
    Abstract: The present invention relates to a composition and method for preventing or treating fatty pancreas, or ameliorating a pancreas disease caused by fatty pancreas, diabetes mellitus or other related disorders.
    Type: Application
    Filed: November 21, 2016
    Publication date: November 15, 2018
    Applicant: NATIONAL DEFENSE EDUCATION AND RESEARCH FOUNDATION
    Inventors: Oliver Yoa-Pu HU, Hsin-Tien HO, Yung-En WU, Hsi-Hui TANG
  • Publication number: 20170172950
    Abstract: A new compound composition that is free of a side effect to a liver and used for alleviating the toxicity of an acetaminophen (APAP) medicament to the liver. The compound composition comprises (a) a pharmaceutically effective amount of acetaminophen and (b) a frequently-used safe and pharmaceutically acceptable excipient that can be combined with one or more than two medicaments that can reduce the toxicity of a drug via liver enzyme CYP2E1 metabolism to the liver.
    Type: Application
    Filed: November 13, 2013
    Publication date: June 22, 2017
    Applicant: NATIONAL DEFENSE EDUCATION AND RESEARCH FOUNDATION
    Inventors: Oliver Yao-Pu Hu, Tung-Yuan Shih
  • Patent number: 8969312
    Abstract: A pharmaceutical composition for treating tuberculotic diseases with no side effect/low side effect is provided by the present invention, which pharmaceutically effective amount of one or more compounds chosen from isoniazid, rifampin, pyrazinamide and ethambutol, and pharmaceutically effective amount of substances which can reduce the side effect of the antituberculosis agents.
    Type: Grant
    Filed: April 20, 2011
    Date of Patent: March 3, 2015
    Assignee: National Defense Education and Research Foundation
    Inventors: Oliver Yaopu Hu, Tonho Young, Chenghuei Hsiong, Wenliang Chang, Tungyuan Shih, Hsintien Ho
  • Publication number: 20140038921
    Abstract: A pharmaceutical composition for treating tuberculotic diseases with no side effect/low side effect is provided by the present invention, which pharmaceutically effective amount of one or more compounds chosen from isoniazid, rifampin, pyrazinamide and ethambutol, and pharmaceutically effective amount of substances which can reduce the side effect of the antituberculosis agents.
    Type: Application
    Filed: April 20, 2011
    Publication date: February 6, 2014
    Applicant: NATIONAL DEFENSE EDUCATION AND RESEARCH FOUNDATION
    Inventors: Oliver Yaopu Hu, Tonho Young, Chenghuei Hsiong, Wenliang Chang, Tungyuan Shih, Hsintien Ho
  • Patent number: 8304394
    Abstract: The present invention features a novel, low side-effect pharmaceutical compound complex, comprising the pharmaceutically effective dose of isoniazid (INH) and pharmaceutically effective dose of one of the following compounds.
    Type: Grant
    Filed: July 23, 2008
    Date of Patent: November 6, 2012
    Assignee: National Defense Education and Research Foundation
    Inventors: Yoapu Oliver Hu, Ton ho Young